Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-11 to 2025-01-03
Current total value of award: $55903.32
Description: 4566718706!KRYSTEXXA 8 MG/ML VIALML